Other current assets (Details) - USD ($) $ in Thousands |
Sep. 30, 2023 |
Dec. 31, 2022 |
---|---|---|
Other current assets | ||
Research and development credits receivable | $ 40,533 | $ 30,162 |
Prepayments | 11,973 | 9,472 |
Clinical materials | 1,290 | 1,279 |
VAT receivable | 1,372 | 490 |
Other current assets | 1,683 | 1,927 |
Total | $ 56,851 | $ 43,330 |
X | ||||||||||
- Definition Clinical materials for use in research and development with alternative future use expected to be consumed within one year or the normal operating cycle. No definition available.
|
X | ||||||||||
- Definition Amount of prepaid expense and other assets current, including accounts receivable. No definition available.
|
X | ||||||||||
- Definition Carrying value of amounts tax credits receivable that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of current assets classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|